Global report - November 24, 2025
AstraZeneca plans USD 2 billion manufacturing investment in Maryland
This is the fourth major US manufacturing investment announced this year.
Biotech Business - November 18, 2025
Sofinnova announces USD 750M fund that will invest in early stage biotechs
European life science VC firm Sofinnova Partners has announced the close of its latest flagship fund, Sofinnova Capital XI, at EUR 650 million (USD 750 million).
Global report - November 18, 2025
World AMR Awareness Week 2025
As one of WHO’s official health campaigns, the World AMR Awareness Week (WAAW) is mandated by the World Health Assembly and is commemorated annually from 18 to 24 November.
Global report - November 15, 2025
MSD to acquire Cidara Therapeutics for USD 9.2 billion
Merck (known as MSD outside of the United States and Canada), and Cidara Therapeutics, a biotech company developing drug-Fc conjugate (DFC) therapeutics, have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Cidara for a total transaction value of approximately USD 9.2 billion.
Global report - November 3, 2025
Pfizer files lawsuit against Metsera and Novo Nordisk for breach of merger agreement
Pfizer has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, in the Delaware Court of Chancery.
Acquisition - November 3, 2025
Thermo Fisher Scientific to acquire Clario
Thermo Fisher Scientific has announced a definitive agreement to acquire Clario Holdings, a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for USD 8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.